A case of combined-histology lung carcinoma (adenocarcinoma plus small cell carcinoma) presenting with changes in the tumor marker profile and histological findings during the clinical course

Takahiro Hirai, Kenta Kambara, Minehiko Inomata*, Ryuji Hayashi, Joji Imura, Kazuyuki Tobe

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background. Ten percent of small cell carcinomas are reported to show mixed histological features. Case. A 68-year-old man presenting with a pulmonary nodule in the right upper lobe was diagnosed with lung adenocarcinoma based on the detection of tumor cells arranged in gland-like structures in a biopsy specimen. However, combined small cell lung cancer was also suspected, because a few tumor cells showed high nuclear-cytoplasmic ratios. Immunohistochemistry was positive for TTF-1, but negative staining for a host of neuroendocrine markers. The plasma CEA level was elevated, while the plasma pro-GRP level was within the normal range. During treatment with a pemetrexed-containing regimen, plasma pro-GRP elevation and liver metastasis were detected. A liver biopsy revealed tumor cells with a high nuclear-cytoplasmic ratio. Immunohistochemistry revealed that the tumor cells were positive for TTF-1 as well as several neuroendocrine tumor markers. Based on these findings, treatment with carboplatin plus etoposide was initiated. Conclusion. In the present case, a repeat tumor biopsy was performed as the patient newly showed the elevation of a plasma neuroendocrine marker, which contributed to the decision on the most appropriate therapeutic regimen.

Original languageEnglish
Pages (from-to)227-230
Number of pages4
JournalJapanese Journal of Lung Cancer
Volume58
Issue number3
DOIs
StatePublished - 2018/06

Keywords

  • Adenocarcinoma
  • Small cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'A case of combined-histology lung carcinoma (adenocarcinoma plus small cell carcinoma) presenting with changes in the tumor marker profile and histological findings during the clinical course'. Together they form a unique fingerprint.

Cite this